These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1987673)

  • 1. Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats.
    Kawamura S; Shirasawa M; Fukasawa H; Yasui N
    Stroke; 1991 Jan; 22(1):51-5. PubMed ID: 1987673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of nilvadipine on rat focal cerebral ischemia.
    Li Y; Kawamura S; Yasui N; Shirasawa M; Fukasawa H
    Exp Brain Res; 1994; 99(1):1-6. PubMed ID: 7925784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):151-5. PubMed ID: 8869150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the calcium antagonist nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Shiino A; Matsuda M; Susumu T; Handa J
    Surg Neurol; 1991 Feb; 35(2):105-10. PubMed ID: 1990476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a Ca2+ entry blocker (nilvadipine) on acute focal cerebral ischemia in rats.
    Kawamura S; Yasui N; Shirasawa M; Fukasawa H
    Exp Brain Res; 1991; 83(2):434-8. PubMed ID: 2022249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of treatment with nilvadipine on cerebral ischemia in rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Tohoku J Exp Med; 1998 Aug; 185(4):239-46. PubMed ID: 9865470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ca++ antagonist and acute brain ischemia: effects of nilvadipine and nicardipine on middle cerebral artery occlusion in rats].
    Shiino A; Matsuda M; Handa J; Morikawa S; Kido C; Inubushi T; Susumu T
    Nihon Geka Hokan; 1991 Jan; 60(1):38-44. PubMed ID: 1819238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nilvadipine, a new calcium channel blocker, reduces ischemic brain injury in rats.
    Takakura S; Susumu T; Satoh H; Mori J; Shiino A; Handa J
    Jpn J Pharmacol; 1991 Aug; 56(4):547-50. PubMed ID: 1744995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nilvadipine (a dihydropyridine-type calcium entry blocker) on cerebral blood flow in acute experimental brain ischemia in rats.
    Tanaka R; Miyasaka Y; Maruyama S; Nagai S; Fujii K
    Neurol Res; 1996 Aug; 18(4):325-8. PubMed ID: 8875450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nilvadipine on neuronal function in the ischemic cat brain.
    Takakura S; Furuichi Y; Satoh H; Mori J; Kohsaka M
    Surg Neurol; 1992 Apr; 37(4):255-60. PubMed ID: 1595035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.
    Belayev L; Alonso OF; Busto R; Zhao W; Ginsberg MD
    Stroke; 1996 Sep; 27(9):1616-22; discussion 1623. PubMed ID: 8784138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride.
    Takakura S; Sogabe K; Satoh H; Mori J; Fujiwara T; Totsuka Z; Tokuma Y; Kohsaka M
    Neurosci Lett; 1992 Jul; 141(2):199-202. PubMed ID: 1436634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage off cytotoxic brain edema after middle cerebral artery occlusion in the feline brain.
    Di X; Bullock R; Watson J; Fatouros P; Chenard B; White F; Corwin F
    Stroke; 1997 Nov; 28(11):2244-51. PubMed ID: 9368572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat.
    Garcia JH; Yoshida Y; Chen H; Li Y; Zhang ZG; Lian J; Chen S; Chopp M
    Am J Pathol; 1993 Feb; 142(2):623-35. PubMed ID: 8434652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Ichiki C; Yatsugi S; Shimizu-Sasamata M; Yamaguchi T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):586-91. PubMed ID: 9840429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete infarct and delayed neuronal death after transient middle cerebral artery occlusion in rats.
    Garcia JH; Liu KF; Ye ZR; Gutierrez JA
    Stroke; 1997 Nov; 28(11):2303-9; discussion 2310. PubMed ID: 9368580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice.
    Paris D; Quadros A; Humphrey J; Patel N; Crescentini R; Crawford F; Mullan M
    Brain Res; 2004 Feb; 999(1):53-61. PubMed ID: 14746921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nilvadipine on the cerebral ischemia-induced impairment of spatial memory and hippocampal apoptosis in rats.
    Iwasaki K; Mishima K; Egashira N; Al-Khatib IH; Ishibashi D; Irie K; Kobayashi H; Egawa T; Fujiwara M
    J Pharmacol Sci; 2003 Oct; 93(2):188-96. PubMed ID: 14578587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nilvadipine prevents the impairment of spatial memory induced by cerebral ischemia combined with beta-amyloid in rats.
    Iwasaki K; Egashira N; Takagaki Y; Yoshimitsu Y; Hatip-Al-Khatib I; Mishima K; Fujiwara M
    Biol Pharm Bull; 2007 Apr; 30(4):698-701. PubMed ID: 17409505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.